Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,570 | 46,628 | 40,622 | 41,249 | 44,920 |
| Marketable Securities | 135,252 | 157,029 | 174,801 | 181,581 | 195,505 |
| Receivables | 704 | 916 | 682 | 1,395 | 2,406 |
| TOTAL | $179,526 | $208,704 | $221,251 | $230,397 | $248,217 |
| Non-Current Assets | |||||
| PPE Net | 54,262 | 56,925 | 59,475 | 61,097 | 62,762 |
| Investments And Advances | 0 | 1,472 | 10,305 | 26,097 | 32,286 |
| Other Non-Current Assets | 51,128 | 51,836 | 52,640 | 54,041 | 55,405 |
| TOTAL | $105,390 | $110,233 | $122,420 | $141,235 | $150,453 |
| Total Assets | $284,916 | $318,937 | $343,671 | $371,632 | $398,670 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,277 | 2,656 | 3,504 | 4,040 | 4,190 |
| Accrued Expenses | 13,642 | 20,024 | 17,571 | 18,182 | 17,213 |
| Other current liabilities | 8,448 | 8,448 | 2,280 | 795 | N/A |
| TOTAL | $30,689 | $36,071 | $28,111 | $28,673 | $28,159 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 582 | 381 | 5 | N/A | 212 |
| Other Non-Current Liabilities | 74,520 | 75,682 | 81,494 | 81,595 | 82,102 |
| TOTAL | $74,520 | $75,682 | $81,494 | $81,595 | $82,102 |
| Total Liabilities | $105,209 | $111,753 | $109,605 | $110,268 | $110,261 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116,559 | 116,264 | 115,352 | 115,330 | 114,633 |
| Common Shares | 116 | 115 | 115 | 115 | 115 |
| Retained earnings | -1,565,522 | -1,534,309 | -1,501,935 | -1,469,685 | -1,435,615 |
| Other shareholders' equity | -74 | 119 | 156 | 65 | 194 |
| TOTAL | $179,707 | $207,184 | $234,066 | $261,364 | $288,409 |
| Total Liabilities And Equity | $284,916 | $318,937 | $343,671 | $371,632 | $398,670 |